RxDoctor Payments DataLook up a doctor →

Pamela Crilley, DO

Hematology & Oncology · Pennington, NJNPI 1538116041

Payments from drug & device makers

$941,232in general payments, 2019–2025

Across 178 payments — averaging $5287.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$925K
  • Aptevo Therapeutics Inc$13K
  • Genentech, Inc.$390
  • Daiichi Sankyo Inc.$283
  • Sanofi$252
  • Novartis$237
  • plus $2K from 35 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$941,232 in reported general payments places this provider in the 95th percentile of 362 hematology & oncology providers in New Jersey.

See all hematology & oncology providers in New Jersey

Medicare billing

Part B allowed, 2024
$98,805
Medicare patients
237
Services billed
2,536

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Pennington

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →